
|Articles|November 29, 2012
New drug promising for psoriatic arthritis
An oral phosphodiesterase 4 inhibitor may offer significant improvement in signs and symptoms of psoriatic arthritis, according to preliminary trial data.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
The Weekly Roundup: December 1-5
3
Nearly Half of Female Psoriasis Patients Report IPV, Study Finds
4
Experts See Promise in AI for Atopic Dermatitis Care
5


















